Prof.Dr. Ali Yagız ÜRESİN

SCI, SSCI ve AHCI İndekslerine Giren Dergilerde Yayınlanan Makaleler

Evaluation of Stress Response in Middle-Aged Male Diabetic Hypertensive Patients

Alloqi Tahirbegolli I., Tahirbegolli B., Şen S., Sayın B., Kaşkal M., Üresin A. Y.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM , cilt.108, sa.9, ss.2307-2314, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

Contextualising adverse events of special interest to characterise the baseline incidence rates in 24 million patients with COVID-19 across 26 databases: a multinational retrospective cohort study

Voss E. A., Shoaibi A., Yin Hui Lai L., Blacketer C., Alshammari T., Makadia R., et al.

ECLINICALMEDICINE , cilt.58, 2023 (SCI-Expanded) Sürdürülebilir Kalkınma

Colchicine for cardiovascular therapy: A drug interaction perspective and a safety meta-analysis

ŞEN S., KARAHAN E., BÜYÜKULAŞ C., POLAT Y. O., ÜRESİN A. Y.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.25, sa.11, ss.753-762, 2021 (SCI-Expanded)

Turkish inappropriate medication use in the elderly (TIME) criteria to improve prescribing in older adults: TIME-to-STOP/TIME-to-START

Bahat G., Ilhan B., Erdogan T., Halil M., Savas S., Ulger Z., et al.

EUROPEAN GERIATRIC MEDICINE , cilt.11, sa.3, ss.491-498, 2020 (SCI-Expanded) Sürdürülebilir Kalkınma

Chrono-pharmacological effects of antihypertensive drugs

Şen S., Kaşkal M., Uresin Y.

EUROPEAN HEART JOURNAL , cilt.41, sa.16, ss.1601, 2020 (SCI-Expanded)

Legal and ethical framework for global health information and biospecimen exchange-an international perspective

Bernasconi L., Sen S., Angerame L., Balyegisawa A. P., Hui D. H. Y., Hotter M., et al.

BMC MEDICAL ETHICS , cilt.21, sa.1, 2020 (SCI-Expanded)

Efficacy and Safety of S-Amlodipine 2.5 and 5 mg/d in Hypertensive Patients Who Were Treatment-Naive or Previously Received Antihypertensive Monotherapy

Sen S., Demir M., Yigit Z., Uresin A. Y.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS , cilt.23, sa.4, ss.318-328, 2018 (SCI-Expanded)

Cardiovascular Efficacy and Safety of Bococizumab in High-Risk Patients

Ridker P. M., Revkin J., Amarenco P., Brunell R., Curto M., Civeira F., et al.

NEW ENGLAND JOURNAL OF MEDICINE , cilt.376, sa.16, ss.1527-1539, 2017 (SCI-Expanded)

EVALUATING THE RELATIONSHIP OF BLOOD PRESSURE, PLASMA ANGIOTENSIN PEPTIDES AND ALDOSTERONE WITH COGNITIVE FUNCTIONS IN PATIENTS WITH HYPERTENSION

Sen S., Gurel N., Ufuktepe B., Ozunal Z. G., Buyuklu C., Uresin Y.

EXCLI JOURNAL , cilt.16, ss.245-255, 2017 (SCI-Expanded)

Cost of heart failure management in Turkey: results of a Delphi Panel

Aras D., Aydogdu S., Bozkurt E., ÇAVUŞOĞLU Y., Eren M., EROL Ç., et al.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.16, sa.8, ss.554-562, 2016 (SCI-Expanded)

Effects of Blood Pressure Lowering With Different Antihypertensive Agents on Cognitive Function and Plasma Brain-derived Neurotrophic Factor Levels: A Comparative Study

Demir M., Gurol A. O., Ozyigit R. T., Uresin A. Y.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY , cilt.67, sa.6, ss.538-543, 2016 (SCI-Expanded)

Economic Impact of Clinical Research to Research Centers and Opportunity Cost for the Reimbursement System in Turkey

Koçkaya G., DEMİR M., Koçkaya P. D., Tatar M., ÜRESİN A. Y.

HEALTH , cilt.7, sa.9, ss.1124-1133, 2015 (SSCI)

Hypertension and valsartan

Kizilirmak P., Uresin A. Y.

ANATOLIAN JOURNAL OF CARDIOLOGY , cilt.14, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

ECONOMIC IMPACT OF CLINICAL RESEARCHES TO THE RESEARCH CENTERS AND REIMBURSEMENT SYSTEMS IN TURKEY

Kockaya G., Kockaya D. P., Demir M., Uresin A. Y.

VALUE IN HEALTH , cilt.17, sa.7, 2014 (SCI-Expanded)

Experience in Alzheimer's Disease Clinical Trials in Turkey

Uresin Y., Ilbars H., Gurvit I. H., Emre M.

GLOBAL CLINICAL TRIALS FOR ALZHEIMER'S DISEASE: DESIGN, IMPLEMENTATION, AND STANDARDIZATION , ss.277-288, 2014 (SCI-Expanded)

RENIN INHIBITORS IN DIABETES AND HYPERTENSION: AN UPDATE

Sen S., Ufuktepe B., Ozunal Z. G., Uresin Y.

EXCLI JOURNAL , cilt.13, ss.1111-1119, 2014 (SCI-Expanded) Sürdürülebilir Kalkınma

The Efficacy and Safety of Triple vs Dual Combination of Angiotensin II Receptor Blocker and Calcium Channel Blocker and Diuretic: A Systematic Review and Meta-Analysis

Kizilirmak P., Berktas M., Uresin Y., YILDIZ O. B.

JOURNAL OF CLINICAL HYPERTENSION , cilt.15, sa.3, ss.193-200, 2013 (SCI-Expanded)

ECONOMIC EFFECT OF CLINICAL TRIALS FOR TURKEY

Kockaya G., Demir M., Uresin A. Y.

VALUE IN HEALTH , cilt.15, sa.7, 2012 (SCI-Expanded)

Comparison of immediate release and extended release formulations in therapy

Ueresin Y., Baran E.

KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY , cilt.21, 2011 (SCI-Expanded)

Direct Inhibition of Renin

Uresin Y., Ozunal Z. G.

TRAKYA UNIVERSITESI TIP FAKULTESI DERGISI , cilt.27, ss.82-84, 2010 (SCI-Expanded)

Potential Adjuvant Effects of Nigella sativa Seeds to Improve Specific Immunotherapy in Allergic Rhinitis Patients

Isik H., Cevikbas A., Gurer U. S., Kiran B., Uresin Y., RAYAMAN P., et al.

MEDICAL PRINCIPLES AND PRACTICE , cilt.19, sa.3, ss.206-211, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

EFFECT OF RENIN-ANGIOTENSIN SYSTEM BLOCKADE ON LEPTIN, ADIPONECTIN, RESISTIN AND INSULIN LEVELS IN PATIENTS WITH METABOLIC SYNDROME

Erbas B., Sidan R., Sabirli S., Gurol A. O., Midi I., Uresin Y.

ATHEROSCLEROSIS SUPPLEMENTS , cilt.9, sa.1, ss.129, 2008 (SCI-Expanded)

EEG AS A POSSIBLE DIAGNOSTIC TOOL FOR MILD COGNITIVE IMPAIRMENT IN ATHEROSCLEROSIS

Uresin Y., Sabirli S., Ozunal Z. G., Karamursel S.

ATHEROSCLEROSIS SUPPLEMENTS , cilt.9, sa.1, ss.155, 2008 (SCI-Expanded)

Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension

Uresin Y., Taylor A. A., Kilo C., Schpe D., Santonastaso M., Ibram G., et al.

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM , cilt.8, sa.4, ss.190-198, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

Aliskiren, the future of renin-angiotensin system blockade?

Uresin Y., Bozkurt M. M., Sabirli S., Ozunal Z.

Expert Review of Cardiovascular Therapy , cilt.5, sa.5, ss.835-849, 2007 (SCI-Expanded)

Efficacy and safety of extended-release fluvastatin in Turkish patients with hypercholesterolaemia: TULIPS (Turkish Lipid Study)

Ilerigelen B., Ueresin Y., San M., Kueltuesay H., Gueneri S., Serdar O. A., et al.

CURRENT MEDICAL RESEARCH AND OPINION , cilt.23, sa.5, ss.1093-1102, 2007 (SCI-Expanded)

Effects of valsartan on stress-induced changes of serum vascular endothelial growth factor and nitric oxide in mice

Erbas B., Uresin Y., Ozek M., Dogru-Abbasoglu S.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , cilt.116, sa.5, ss.601-611, 2006 (SCI-Expanded)

Influence of polymerization method, curing process, and length of time of storage in water on the residual methyl methacrylate content in dental acrylic resins

Bayraktar G., Guvener B., Bural C., Uresin Y.

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS , sa.2, ss.340-345, 2006 (SCI-Expanded)

Effects of nitrendipine on reference and working memory of rats in three-panel runway

Celik P., Uresin Y., Tonyali H.

PHARMACOLOGICAL RESEARCH , cilt.50, sa.3, ss.367-370, 2004 (SCI-Expanded)

Alpha rhythm of the EEG modulates visual detection performance in humans

Ergenoglu T., Demiralp T., Bayraktaroglu Z., Ergen M., Beydagi H., Uresin Y.

COGNITIVE BRAIN RESEARCH , cilt.20, sa.3, ss.376-383, 2004 (SCI-Expanded)

Losartan may prevent the elevation of plasma glucose, corticosterone and catecholamine levels induced by chronic stress

URESIN Y., ERBAS B., OZEK M., OZKOK E., Gurol A. O.

JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM , cilt.5, sa.2, ss.93-96, 2004 (SCI-Expanded) Sürdürülebilir Kalkınma

The effects of losartan and immobilization stress on heart rate variability and plasma corticosterone levels in rats

Uresin A. Y., Tonyali H., Karamursel S.

INTERNATIONAL JOURNAL OF NEUROSCIENCE , cilt.114, sa.3, ss.365-379, 2004 (SCI-Expanded)

Losartan may prevent the elevation of plasma glucose levels induced by chronic stress

Uresin Y., Erbas B., Ozek M.

POLISH JOURNAL OF PHARMACOLOGY , cilt.56, sa.2, ss.271-273, 2004 (SCI-Expanded)

Comparison of the effects of specific and nonspecific inhibition of nitric oxide synthase on morphine analgesia, tolerance and dependence in mice

Ozek M., Uresin Y., Gungor M.

LIFE SCIENCES , cilt.72, sa.17, ss.1943-1951, 2003 (SCI-Expanded)

A model of pharmacology education: The experience of Istanbul Medical Faculty

Eroglu L., Uresin Y.

JOURNAL OF CLINICAL PHARMACOLOGY , cilt.43, sa.3, ss.237-242, 2003 (SCI-Expanded)

Protective effects of dextromethorphan and tizanidine on ouabain-induced arrhythmias

Uresin Y., Ozek M., Sevgi S.

METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY , cilt.24, sa.7, ss.421-423, 2002 (SCI-Expanded)

Changes in HDL-cholesterol levels in response to stress and losartan

Uresin Y., Sevgi S., Ozek M., Guvener B., Canberk A.

ATHEROSCLEROSIS , cilt.146, 1999 (SCI-Expanded)

Effects of slow cortical potential shifts on P300 response

Ergenoglu T., Demiralp T., Beydagi H., Karamursel S., Devrim M., Ermutlu N.

INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY , cilt.30, ss.239, 1998 (SCI-Expanded)

Electrophysiological effects of reversible MAO-A inhibitors Moclobemid in healthy volunteers

Ermutlu N., Uresin Y., Demiralp T.

JOURNAL OF PSYCHOPHYSIOLOGY , cilt.12, sa.1, ss.98, 1998 (SCI-Expanded)

Protective role of immobilization on ouabain-induced arrhythmias

Uresin Y., Eroglu L., Yildiran G., Guvener B., Ozkok E.

METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY , cilt.19, sa.9, ss.633-636, 1997 (SCI-Expanded)

Optimizing the absorption of valspodar, a P-glycoprotein modulator .1. Selecting an oral formulation and exploring its clinical pharmacokinetics/dynamics

Mueller E., Kovarik J., Uresin Y., PreisigFluckiger S., Hensel S., Lucker P., et al.

JOURNAL OF CLINICAL PHARMACOLOGY , cilt.37, sa.11, ss.1001-1008, 1997 (SCI-Expanded)

Effects of opioid-type stressors on serum digoxin-like immunoreactivity in rats

Uresin Y., Eroglu L., Yildiran G.

METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY , cilt.18, sa.9, ss.569-571, 1996 (SCI-Expanded)

MORPHINE AND NALOXONE ACT SIMILARLY ON GLUTAMATE-CAUSED GUINEA-PIG ILEUM CONTRACTION

KOYUNCUOGLU H., URESIN Y., ESIN Y., ARICIOGLU F.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR , cilt.43, sa.2, ss.479-482, 1992 (SCI-Expanded)

EFFECTS OF TIZANIDINE ON MORPHINE PHYSICAL-DEPENDENCE - ATTENUATION AND INTENSIFICATION

KOYUNCUOGLU H., ARICIOGLU F., URESIN Y., DIZDAR Y., ESIN Y.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR , cilt.42, sa.4, ss.693-698, 1992 (SCI-Expanded)

Diğer Dergilerde Yayınlanan Makaleler

Evaluation of clinical trials of the plants, which have ethnobotanical uses for skin disorders in Turkey: a review

Alan Z., Özgüldü H., Erdal M. S., Yaman Bucak A., Üresin A. Y., Akalın Uruşak E.

Clinical Phytoscience , cilt.79, sa.7, ss.1-29, 2021 (Hakemli Dergi)

COVID-19 and RAAS blockers: Could Aliskiren be an appropriate option?

Sen S., Uresin A. Y.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , cilt.48, sa.7, ss.631-634, 2020 (Hakemli Dergi) Sürdürülebilir Kalkınma

Traditional Chinese medicine practices used in COVID-19 (Sars-cov 2/Coronavirus-19) treatment in clinic and their effects on the cardiovascular system COVID-19 (Sars-cov 2/Koronavirüs-19) tedavisinde klinikte kullanilan geleneksel Çin tibbi bitkileri ve kardiyovasküler sisteme etkileri

Akalın E., Ekici M., Alan Z., Elevli Özbir E., Bucak Yaman A., Aobuliaikemu N., et al.

Turk Kardiyoloji Dernegi Arsivi , cilt.48, sa.4, ss.410-424, 2020 (ESCI)

Renin-angiotensin system in stress response and the effect of chronic exercise in healthy volunteers

Ozunal Z. G., Sabırlı S., Şen S., Karamürsel S., Ömer B., Yıldız S., et al.

Annals of Medical Research , cilt.27, sa.4, ss.988-992, 2020 (Hakemli Dergi)

Evaluation of statin use on LDL cholesterol levels in Turkey: A systematic review

Kizilirmak P., Ongen Z., Kayikcioglu M., Tokgozoglu L.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , cilt.48, sa.2, ss.137-148, 2020 (ESCI)

Dislipidemi ve Pitavastatin

ÜRESİN A. Y., ŞEN S.

Klinik Aktüel Tıp İç Hastalıkları Forumu , ss.40-46, 2018 (Hakemsiz Dergi)

Renin-angiotensin-aldosterone system blockers and cardiovascular outcomes: a meta-analysis of randomized clinical trials

Kizilirmak P., Uresin Y., Ozdemir O., Avci B. K., Tokgozoglu L., Ongen Z.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , cilt.45, sa.1, ss.49-66, 2017 (ESCI)

Vadi Tepe Oranı mı? Yarılanma Ömrü mü?

ÜRESİN A. Y., ŞEN S.

Medilog Tıp Günlüğü Hipertansiyon Özel Sayı , sa.2, ss.46-48, 2015 (Hakemsiz Dergi)

Aliskiren: review of efficacy and safety data with focus on past and recent clinical trials

Şen S., Sabırlı S., Özyığıt T., Uresın Y.

THERAPEUTIC ADVANCES IN CHRONIC DISEASE , cilt.4, sa.5, ss.232-241, 2013 (Hakemli Dergi) Sürdürülebilir Kalkınma

Pharmacological properties and clinical use of candesartan: Review Kandesartanin farmakolojik özellikleri ve klinik kullanimi

Üresin A. Y., Şen S.

Turkiye Klinikleri Cardiovascular Sciences , cilt.24, sa.2, ss.134-140, 2012 (Scopus)

The efficacy and undesired effects of high dosage zinc treatment

Kockaya G., Ufuktepe B., Kockaya P. D., Sen S., Altunel O., Uresın Y.

Journal of Applied Pharmaceutical Science , cilt.2, sa.3, ss.157-159, 2012 (Scopus)

The future of renin inhibition

ÜRESİN A. Y., Baran E.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , cilt.37, ss.32-38, 2009 (ESCI) Sürdürülebilir Kalkınma

Safety of statins

Uresin Y., Sabirli S.

TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY , cilt.35, ss.15-23, 2007 (ESCI) Sürdürülebilir Kalkınma

Kuzularda Enrofloksasinin Biyoyararlanımı

YILDIRIM M., ÜRESİN A. Y., DEMİREL H., (İLTER) BAKIREL T., BAKIREL U.

İSTANBUL ÜNİVERSİTESİ VETERİNER FAKÜLTESİ DERGİSİ , cilt.22, sa.1, ss.49-55, 1996 (Scopus)

Endogenous digoxin like activity in patients with hyperbilirubinemia

Tascioglu C., Azezli A., Orhan Y., Uresin Y., Ates A.

Istanbul Tip Fakultesi Mecmuasi , cilt.56, sa.2, ss.15-17, 1993 (Scopus)

Hakemli Kongre / Sempozyum Bildiri Kitaplarında Yer Alan Yayınlar

Türkiye'de Hipertansiyon Tedavisinde Geleneksel Olarak Kullanılan Bitkilerin Etkinlik, Güvenlik ve Etki Mekanizmalarının Değerlendirilmesi

Ekici M., Tuncay H. O., Akalın E., Gürel N., Üresin A. Y.

XXIV. Bitkisel İlaç Hammaddeleri Toplantısı, Ankara, Türkiye, 23 - 26 Haziran 2022, ss.150-151

Hipertansiyon Hastalarında Stres Yanıtındaki Değişimlerin Kognitif Fonksiyonlara ve Kliniğe Yansımalarının Biyokimyasal ve Elektrofizyolojik Yöntemlerle Araştırılması

Büyüklü Ç., Şen S., Gürel N., Demiralp T., Üresin A. Y.

25. Ulusal Farmakoloji Kongresi, Aydın, Türkiye, 4 - 07 Kasım 2019, ss.134

Türkiye Yaşlılarda Uygunsuz İlaç Kullanım Kriterleri - TIME Kriterleri

BAHAT-ÖZTÜRK G., İlhan B., Erdoğan T., Halil M., savaş S., AKYÜZ F., et al.

2. Uluslararası ve 12. Akademik Geriatri Kongresi, Antalya, Türkiye, 24 - 28 Nisan 2019, ss.1

İyi Klinik Uygulamalar Çerçevesinde Klinik Araştırma Eğitim Değerlendirmesi: İstanbul Tıp Fakültesi Tıbbi ve Klinik Farmakoloji Uygulamaları (INSAC-18-1112)(ISBN: 978-605-69062-0-6)

DEMİR M., DİZDAR M. Y., BEBEK N., AKKAYA V. A., TÜKEK T., GÜRSES R. C., et al.

International Science and Academic Congress'18, Konya, Türkiye, 8 - 09 Aralık 2018, cilt.1, ss.99-103

Cost of Obesity for Turkey

Kockaya G., Tatar M., Ergin G., Atikeler K., Ozmen M., Gorgun M., et al.

18th World Congress of the International-Federation-for-the-Surgery-of-Obesity-and-Metabolic-Disorders (IFSO), İstanbul, Türkiye, 28 - 31 Ağustos 2013, cilt.23, ss.1143 Sürdürülebilir Kalkınma

Economic Value of Obesity Surgery for Turkey

Kockaya G., Atikeler K., Ergin G., Tatar M., Ozmen M., Gorgun M., et al.

18th World Congress of the International-Federation-for-the-Surgery-of-Obesity-and-Metabolic-Disorders (IFSO), İstanbul, Türkiye, 28 - 31 Ağustos 2013, cilt.23, ss.1143 Sürdürülebilir Kalkınma

Operational Cost of Obesity Surgery for Turkey

Kockaya G., Ergin G., Atikeler K., Tatar M., Ozmen M., Gorgun M., et al.

18th World Congress of the International-Federation-for-the-Surgery-of-Obesity-and-Metabolic-Disorders (IFSO), İstanbul, Türkiye, 28 - 31 Ağustos 2013, cilt.23, ss.1142-1143 Sürdürülebilir Kalkınma

Aliskiren monotherapy lowers blood pressure more effectively than ramipril monotherapy in patients with diabetes and grade 2 hypertension: Subgroup analysis of an 8-week, double-blind trial

Uresin Y., Taylor A. A., Kilo C., Fang H., Lukashevich V., Keefe D. L.

18th Annual Meeting of the European-Society-of-Hypertension/22nd Scientific Meeting of the International-Society-of-Hypertension, Berlin, Almanya, 14 - 19 Haziran 2008, cilt.26 Sürdürülebilir Kalkınma

Aliskiren, a novel renin inhibitor, has greater BP lowering than ramipril and additional bp lowering when combined with ramipril in patients with diabetes and hypertension

Uresin Y., Taylor A., Kilo C., Tschope D., Santonastaso M., Ibram G., et al.

16th European Meeting on Hypertension, Madrid, İspanya, 12 - 15 Haziran 2006, cilt.24 Sürdürülebilir Kalkınma

Plasma Corticosterone Levels of Rats Trained for Reference Memory Test in Three-Panel Runway

YAMANTÜRK ÇELİK A. P., TONYALI H., ÜRESİN A. Y.

Turkish Pharmacological Society, 17th. National Congress of Pharmacology, 1st Clinical Pharmacology Symposium & Joint Meeting of The Turkish & Dutch Pharmacological Societies, Antalya, Türkiye, 1 - 04 Kasım 2003, ss.62

Kitap & Kitap Bölümleri

Yetim İlaçlar

Şen S., Üresin A. Y.

Nadir Hastalıklar, Uğur Özbek, Editör, Türkiye Klinikleri Yayınevi, Ankara, ss.91-95, 2021

COVID-19 (SARS-CoV-2) Tedavisinde Klinik Çalışmalarda Yer Alan Bitkisel Kökenli Doğal Bileşikler

Akalın Uruşak E., Ekici M., Alan Z., Yaman Bucak A., Üresin A. Y.

Covid-19: Moleküler ve Klinik Yaklaşım, Bedia Çakmakoğlu,Sema Sırma Ekmekçi,Umut Can Küçüksezer,Vuslat Yılmaz,Günnur Deniz, Editör, Istanbul University, İstanbul, ss.263-284, 2020 Sürdürülebilir Kalkınma

Metrikler

Yayın

Atıf (WoS)

1172

H-İndeks (WoS)

Atıf (Scopus)

1982

H-İndeks (Scopus)

Proje

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler